← All organizations

SC Liver Research Consortium, LLC

Academic/Hospital

Also known as: SC Liver Research Consortium, LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Dec 15, 2020

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 2 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

regorafenib

Indications

Studied for

Recent trials (3)

NCT04476329Lead sponsorPhase 2Dec 15, 2020
NCT02214420Reponsible party - principal investigatorPhase 4Oct 1, 2014
NCT02214420Lead sponsorPhase 4Oct 1, 2014

Details

Last known activity: Dec 15, 2020